CUSIP: 210373106
Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,980,278
-
Share change
-
+3,682,381
-
Total reported value
-
$129,069,236
-
Price per share
-
$6.46
-
Number of holders
-
47
-
Value change
-
+$23,394,438
-
Number of buys
-
21
-
Number of sells
-
16
Quarterly Holders Quick Answers
What is CUSIP 210373106?
CUSIP 210373106 identifies CNST - CONSTELLATION PHARMCETICLS I - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2019
-
Previous quarter:
Q2 2019
Recent filing periods for CUSIP 210373106:
Institutional Holders of CONSTELLATION PHARMCETICLS I - COM (CNST) as of Q3 2019
As of 30 Sep 2019,
CONSTELLATION PHARMCETICLS I - COM (CNST) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,980,278 shares.
The largest 10 holders included
Svennilson Peter, TRV GP, LLC, REGENTS OF THE UNIVERSITY OF CALIFORNIA, Casdin Capital, LLC, Cormorant Asset Management, LP, FMR LLC, BlackRock Inc., ORBIMED ADVISORS LLC, VHCP Management II, LLC, and VANGUARD GROUP INC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.